...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Reports of Exempt Distribution
1
Feb 04, 2023 09:01AM

Hi koo.

Just a quick note to thank you for keeping us informed of the financings. They do give us clues about what this "mushroom management" company is up too.

GLTA

Toinv 

1
Feb 24, 2023 10:39AM
Share
New Message
Please login to post a reply